Master thesis project in Medicinal Chemistry and Nuclear Medicine (published: 05.06.18)
A Master thesis project will be available from August 2018 under the supervision of Dr. Xinyu Chen (Department of Nuclear Medicine/Comprehensive Heart Failure Center, University Hospital of Würzburg) and Prof. Dr. Michael Decker (Institute of Pharmacy and Food Chemistry, University of Würzburg), who will act as the formal supervisor for the faculty. The project is funded within a DFG grant as a “mini-job” position for six months. It requires a Master student, who would like to do his/her thesis/research project in a multidisciplinary background focusing on organic syntheses. The target compounds will be used in cardiac positron emission tomography (PET) studies targeting the norepinephrine transporter of the heart.
The project requires one Master student with organic chemistry / pharmacy background and practical experiences in organic synthesis, spectral analysis as well as compound purification. Fluent English speaking and writing are necessary.
Those who are interested please contact us:
Promotion im Internationalen Doktorandenkolleg "Receptor Dynamics" des Elitenetzwerk Bayern
Für die zweite Förderphase des Doktorandenkollegs "Receptor Dynamics" (2018-2022) stehen sieben Promotionsstellen an drei Universitäten in Bayern zur Verfügung.
PhD position „Thorough characterization of CO-releasing molecules and Implementation of DIY building kit of a CO-releasing formulation”
The Clinical Pharmacy in collaboration with the chair for Drug Delivery and Formulation at the University of Würzburg in Würzburg (Germany) is offering a PhD position as of January 2019.
The successful applicant will work on the characterization of the synthesis process of an already known carbon monoxide releasing molecule and on the characterization of the compound itself using the analytical techniques necessary (e.g. HPLC, LC-MS, GC, ICP‑MS). GLP-like documentation and validation of synthesis and analytical procedures will eventually lead to a well-characterized CO-releasing molecule that is to be used in early in-vivo studies. The successful candidate will also be involved in the planning and implementation of a novel 3D printed device for the oral administration of CO-releasing molecules in the form of a do-it-yourself building kit in cooperation with the SKZ (Süddeutsches Kunstoff-Zentrum).
Please read the full texthere.